Sarepta Therapeutics Inc

18 set 2026, 19:51 UTC

Sarepta Therapeutics Inc shares fell sharply, continuing a significant decline since Thursday and trading well below its 20-day moving average.

17 set 2026, 20:02 UTC

Sarepta Therapeutics Inc shares are sharply higher, showing notable volatility and remaining well above the 20-day moving average since Wednesday's close.

16 set 2026, 23:06 UTC

Sarepta Therapeutics Inc. is trading modestly higher in after-market hours following a notable early spike, despite closing lower in three consecutive sessions.

14 set 2026, 20:07 UTC

Sarepta Therapeutics shares are higher, reflecting broader market strength despite pulling back from an earlier session peak. No specific news was identified for the movement.

12 set 2026, 00:01 UTC

Sarepta Therapeutics Inc shares are lower in after-market trading, following a decline earlier in the session amid broader inflation concerns ahead of a Federal Reserve meeting.

11 set 2026, 23:31 UTC

Sarepta Therapeutics Inc shares are lower in after-market hours with no specific news to explain the decline amid broader market speculation on Federal Reserve rate hikes.

10 set 2026, 20:03 UTC

Sarepta Therapeutics Inc shares are lower today, continuing a decline since Wednesday. No specific news was identified to explain the drop.

9 set 2026, 23:21 UTC

Sarepta Therapeutics shares are lower in after-market hours, following a broader market trend amid rising U.S. Treasury yields impacting borrowing costs.

8 set 2026, 23:21 UTC

Sarepta Therapeutics is higher in after-market trading amid social media interest in its $2.1 billion market cap and revenue projections for fiscal year 2026.

4 set 2026, 23:25 UTC

Sarepta Therapeutics Inc. shares declined after-market, reflecting unusual weakness since Friday's close, despite remaining above the 20-day moving average.

3 set 2026, 23:36 UTC

Sarepta Therapeutics Inc. shares traded roughly flat after market hours, while major indices gained amid easing interest rate concerns.

2 set 2026, 20:02 UTC

Sarepta Therapeutics shares are higher as investor interest grows ahead of clinical data for treatments targeting muscular dystrophy, despite a pullback from session highs.

1 set 2026, 20:09 UTC

Sarepta Therapeutics Inc shares are higher today, supported by gains in the Biotechnology sub-sector. The stock remains above its 20-day moving average.

31 ago 2026, 20:07 UTC

Sarepta Therapeutics shares are higher amid broader market concerns over inflation, with no specific company news identified to explain the movement.

28 ago 2026, 19:51 UTC

Sarepta Therapeutics reported a 34% revenue decline to $401.3 million for Q2 2026, as execution risks weigh on shares during the current session.

27 ago 2026, 23:02 UTC

Sarepta Therapeutics shares declined in after-market trading amid a broader market pullback, despite earlier gains during the session. No specific news was identified.

26 ago 2026, 20:08 UTC

Sarepta Therapeutics Inc shares are higher today amid broader market gains, despite no specific company news identified. Recent inflation data may be influencing market trends.

25 ago 2026, 19:26 UTC

Sarepta Therapeutics Inc. shares are higher today amid notable volatility, despite no specific news to explain the movement. Broader market conditions support higher valuations.

24 ago 2026, 20:06 UTC

Sarepta Therapeutics shares decline amid investigation into potential fiduciary breaches and safety concerns regarding its gene therapy, Elevidys.

21 ago 2026, 19:26 UTC

Sarepta Therapeutics Inc is trading lower today, with no specific news identified for the decline. Broader market trends show a rebound in U.S. stocks.

20 ago 2026, 23:56 UTC

Sarepta Therapeutics Inc. shares traded roughly flat in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month range.

19 ago 2026, 23:11 UTC

Sarepta Therapeutics shares are lower in after-market hours amid a broader decline in the Biotechnology sub-sector, showing unusual volatility during the session.

18 ago 2026, 23:11 UTC

Sarepta Therapeutics Inc shares are lower in after-market hours, retracing gains amid broader market weakness linked to rising sovereign bond yields and inflation concerns.

17 ago 2026, 19:36 UTC

Sarepta Therapeutics Inc shares are higher, continuing their advance since Friday's close and trading above the 20-day moving average. No specific news was identified.

14 ago 2026, 19:36 UTC

Sarepta Therapeutics shares are lower today amid broader market sentiment following a reported decline in retail sales for July. No specific company news was identified.

13 ago 2026, 19:36 UTC

Sarepta Therapeutics shares are trading roughly flat, with no specific news identified. The price remains significantly above the 20-day moving average.

12 ago 2026, 23:51 UTC

Sarepta Therapeutics Inc shares are lower in after-market hours, continuing a decline since Wednesday's close, with no specific news identified to explain the drop.

11 ago 2026, 23:51 UTC

Sarepta Therapeutics Inc shares are lower in after-market trading. No specific news was identified to explain the movement amid broader market focus on inflation data.

10 ago 2026, 23:52 UTC

Sarepta Therapeutics shares are lower in after-market hours, with no specific news identified for the decline amid broader market sentiment influenced by labor report data.

7 ago 2026, 19:36 UTC

Sarepta Therapeutics reports Q2 2026 revenue of $401.3 million, down from $611.1 million a year earlier, with shares trading lower during the session.